ImageneBio, Inc.
IMA
$6.63
$0.426.76%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 09/30/2024 | ||
|---|---|---|---|---|---|
| Revenue | -- | -- | 800.00K | 3.50M | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -- | -- | 800.00K | 3.50M | |
| Cost of Revenue | -- | -- | -- | -- | |
| Gross Profit | -- | -- | 800.00K | 3.50M | |
| SG&A Expenses | 11.04M | 1.71M | 2.76M | 1.65M | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | 26.59M | 7.36M | 6.80M | 5.54M | |
| Operating Income | -26.59M | -7.36M | -6.00M | -2.04M | |
| Income Before Tax | -24.85M | -7.59M | -6.08M | -3.18M | |
| Income Tax Expenses | -74.00K | -- | -- | -- | |
| Earnings from Continuing Operations | -24.78M | -7.59M | -6.08M | -3.18M | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -24.78M | -7.59M | -6.08M | -3.18M | |
| EBIT | -26.59M | -7.36M | -6.00M | -2.04M | |
| EBITDA | -26.59M | -7.36M | -5.99M | -1.96M | |
| EPS Basic | -3.01 | -7.60 | -0.02 | -4.41 | |
| Normalized Basic EPS | -1.82 | -3.36 | -0.01 | -1.42 | |
| EPS Diluted | -3.01 | -7.60 | -0.02 | -4.41 | |
| Normalized Diluted EPS | -1.82 | -3.36 | -0.01 | -1.42 | |
| Average Basic Shares Outstanding | 8.53M | 1.41M | 462.13M | 1.40M | |
| Average Diluted Shares Outstanding | 8.53M | 1.41M | 462.13M | 1.40M | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |